LFST - LifeStance Health Group, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$9.70
DETAILS
HIGH:
$11.00
LOW:
$8.00
MEDIAN:
$10.00
CONSENSUS:
$9.70
UPSIDE:
31.26%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 1,424.3 | 1,251.0 | 1,055.7 | 859.5 | 667.5 | 377.2 | 212.5 |
| Cost of Revenue | 1,017.9 | 848.6 | 753.6 | 622.5 | 466.0 | 242.9 | 150.1 |
| Gross Profit | 406.3 | 402.4 | 302.1 | 237.0 | 201.5 | 134.3 | 62.4 |
| Operating Expenses | |||||||
| R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 382.2 | 363.1 | 410.8 | 378.0 | 433.7 | 87.8 | 41.1 |
| Other Expenses | 0 | 71.0 | 80.4 | 69.2 | 54.1 | 31.0 | 6.1 |
| Operating Expenses | 380.6 | 434.0 | 491.2 | 447.2 | 487.9 | 118.9 | 47.2 |
| Operating Income | |||||||
| Operating Income | 25.7 | (31.6) | (189.1) | (210.2) | (286.4) | 15.4 | 15.2 |
| Interest Expense | 11.7 | 26.5 | 21.2 | 19.9 | 38.9 | 22.1 | 5.4 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 22.1 | 0 |
| Profitability | |||||||
| EBITDA | 78.8 | 39.9 | (104.9) | (143.6) | (240.1) | 8.8 | 21.3 |
| EBIT | 24.0 | (31.1) | (185.4) | (212.8) | (294.2) | (22.3) | 15.2 |
| Income Before Tax | 12.4 | (57.6) | (206.6) | (232.7) | (333.1) | (44.4) | 7.9 |
| Income Tax Expense | 2.7 | (0.2) | (20.3) | (17.2) | (25.9) | (6.3) | 2.2 |
| Net Income | 9.7 | (57.4) | (186.3) | (215.6) | (307.2) | (38.1) | 5.7 |
| Per Share Data | |||||||
| EPS (Basic) | 0.03 | -0.15 | -0.51 | -0.61 | -1.05 | -0.83 | 0.02 |
| EPS (Diluted) | 0.02 | -0.15 | -0.51 | -0.61 | -1.05 | -0.83 | 0.02 |
| Shares Outstanding | 386.0 | 379.1 | 367.5 | 355.3 | 327.5 | 373.6 | 373.6 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 248.6 | 154.6 | 78.8 | 108.6 | 148.0 | 18.8 | 3.5 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 95.7 | 132.0 | 125.6 | 101.5 | 99.3 | 43.7 | 19.1 |
| Inventory | 0 | 0 | 0 | 0 | 38.1 | 0 | 0 |
| Other Current Assets | 71.8 | 14.9 | 10.7 | 11.0 | (25.7) | 7.8 | 0 |
| Total Current Assets | 416.2 | 312.5 | 225.7 | 233.2 | 266.5 | 76.3 | 27.4 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 311.3 | 313.9 | 358.9 | 393.6 | 152.2 | 59.3 | 22.4 |
| Goodwill | 1,293.3 | 1,293.3 | 1,293.3 | 1,272.9 | 1,204.5 | 1,098.7 | 214.6 |
| Intangible Assets | 177.7 | 190.8 | 221.1 | 263.3 | 300.4 | 332.8 | 15.0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | (42.6) | (10.8) | 0 |
| Other Non-Current Assets | 5.4 | 7.7 | 10.9 | 10.8 | 3.4 | 2.6 | 1.4 |
| Total Non-Current Assets | 1,787.7 | 1,805.8 | 1,884.2 | 1,940.6 | 1,660.6 | 1,493.5 | 253.4 |
| Total Assets | 2,203.9 | 2,118.3 | 2,110.0 | 2,173.9 | 1,927.1 | 1,569.7 | 280.8 |
| Current Liabilities | |||||||
| Account Payables | 6.1 | 7.2 | 23.2 | 24.4 | 14.2 | 7.7 | 8.3 |
| Short-Term Debt | 45.5 | 7.2 | 2.9 | 2.3 | 1.3 | 3.7 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 76.1 | 0 | 0 |
| Other Current Liabilities | 200.3 | 19.0 | 8.9 | 16.5 | (50.8) | 19.2 | 23.2 |
| Total Current Liabilities | 252.0 | 228.9 | 202.9 | 176.0 | 116.8 | 75.9 | 55.0 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 148.6 | 279.8 | 280.3 | 225.1 | 157.4 | 362.5 | 79.3 |
| Deferred Tax Liabilities | 16.4 | 14.3 | 15.6 | 38.7 | 54.3 | 81.2 | 0.9 |
| Other Non-Current Liabilities | 266.0 | 0.3 | 1.0 | 2.8 | 53.6 | 17.2 | 311.9 |
| Total Non-Current Liabilities | 431.0 | 443.1 | 478.2 | 479.1 | 265.3 | 496.0 | 392.1 |
| Total Liabilities | 682.9 | 672.0 | 681.0 | 655.1 | 382.1 | 571.9 | 447.1 |
| Stockholders' Equity | |||||||
| Common Stock | 3.9 | 3.8 | 3.8 | 3.8 | 3.7 | 1,009.5 | 0.0 |
| Retained Earnings | (808.6) | (818.3) | (760.8) | (572.6) | (357.1) | (13.1) | (166.4) |
| Accumulated Other Comprehensive Income | 0 | 0.9 | 2.3 | 3.3 | 0 | (35) | 0 |
| Total Stockholders' Equity | 1,521.0 | 1,446.3 | 1,428.9 | 1,518.7 | 1,545.0 | 997.8 | (166.4) |
| Total Liabilities & Equity | 2,203.9 | 2,118.3 | 2,110.0 | 2,173.9 | 1,927.1 | 1,569.7 | 280.8 |
| Debt Metrics | |||||||
| Total Debt | 194.1 | 485.2 | 511.0 | 478.8 | 158.7 | 366.3 | 79.3 |
| Net Debt | (54.5) | 330.6 | 432.2 | 370.2 | 10.7 | 347.4 | 75.8 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | 9.7 | (57.4) | (186.3) | (215.6) | (307.2) | (38.1) | 5.7 |
| Depreciation & Amortization | 54.8 | 71.0 | 80.4 | 69.2 | 54.1 | 31.0 | 6.1 |
| Stock-Based Compensation | 74.7 | 76.2 | 99.4 | 187.4 | 259.4 | 1.5 | 0.1 |
| Change in Working Capital | (40.3) | (27.4) | (33.7) | (16.9) | 2.1 | (0.8) | 3.0 |
| Other Non-Cash Items | 45.0 | 45.9 | 45.2 | 45.4 | 27.8 | (2.2) | 0.5 |
| Operating Cash Flow | 146.2 | 107.3 | (16.9) | 52.8 | 9.4 | (8.5) | 17.0 |
| Investing Activities | |||||||
| Capital Expenditure | (36.1) | (21.6) | (40.5) | (79.3) | (94.5) | (38.1) | (14.3) |
| Acquisitions | 0 | 0 | (19.8) | (60.2) | (99.6) | (823.1) | (59.1) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (36.1) | (21.6) | (60.3) | (139.5) | (194.1) | (861.2) | (73.4) |
| Financing Activities | |||||||
| Net Debt Issuance | (7.2) | (1.7) | 55.3 | 69.6 | (223.8) | 291.4 | 55.5 |
| Stock Repurchased | 0 | 0 | 0 | (0.9) | 0 | (1) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (8.7) | (8.3) | (7.9) | (21.4) | (12.3) | 600.9 | (7.0) |
| Financing Cash Flow | (16.0) | (9.9) | 47.4 | 47.3 | 313.9 | 912.3 | 48.5 |
| Cash Position | |||||||
| Net Change in Cash | 94.1 | 75.7 | (29.8) | (39.4) | 129.2 | 15.3 | (7.9) |
| Cash at Beginning | 154.6 | 78.8 | 108.6 | 148.0 | 18.8 | 3.5 | 11.3 |
| Cash at End | 248.6 | 154.6 | 78.8 | 108.6 | 148.0 | 18.8 | 3.5 |
| Free Cash Flow | 110.0 | 85.7 | (57.4) | (26.5) | (85.1) | (46.6) | 2.7 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 1,424.3 | 1,251.0 | 1,055.7 | 859.5 | 667.5 | 377.2 | 212.5 |
| Gross Profit | 406.3 | 402.4 | 302.1 | 237.0 | 201.5 | 134.3 | 62.4 |
| Operating Income | 25.7 | (31.6) | (189.1) | (210.2) | (286.4) | 15.4 | 15.2 |
| Net Income | 9.7 | (57.4) | (186.3) | (215.6) | (307.2) | (38.1) | 5.7 |
| EPS (Diluted) | 0.02 | -0.15 | -0.51 | -0.61 | -1.05 | -0.83 | 0.02 |
| Balance Sheet | |||||||
| Cash & Equivalents | 248.6 | 154.6 | 78.8 | 108.6 | 148.0 | 18.8 | 3.5 |
| Total Assets | 2,203.9 | 2,118.3 | 2,110.0 | 2,173.9 | 1,927.1 | 1,569.7 | 280.8 |
| Total Debt | 194.1 | 485.2 | 511.0 | 478.8 | 158.7 | 366.3 | 79.3 |
| Stockholders' Equity | 1,521.0 | 1,446.3 | 1,428.9 | 1,518.7 | 1,545.0 | 997.8 | (166.4) |
| Cash Flow | |||||||
| Operating Cash Flow | 146.2 | 107.3 | (16.9) | 52.8 | 9.4 | (8.5) | 17.0 |
| Capital Expenditure | (36.1) | (21.6) | (40.5) | (79.3) | (94.5) | (38.1) | (14.3) |
| Free Cash Flow | 110.0 | 85.7 | (57.4) | (26.5) | (85.1) | (46.6) | 2.7 |